Axa S.A. lifted its position in Celsius Holdings, Inc. (NASDAQ:CELH - Free Report) by 435.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 224,428 shares of the company's stock after buying an additional 182,508 shares during the quarter. Axa S.A. owned about 0.10% of Celsius worth $12,813,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also modified their holdings of CELH. Toronto Dominion Bank boosted its holdings in Celsius by 22.8% during the second quarter. Toronto Dominion Bank now owns 17,893 shares of the company's stock valued at $1,022,000 after acquiring an additional 3,326 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp boosted its stake in Celsius by 63.4% during the 2nd quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 29,026 shares of the company's stock valued at $1,657,000 after purchasing an additional 11,258 shares during the period. Xponance Inc. grew its holdings in Celsius by 7.8% in the 2nd quarter. Xponance Inc. now owns 40,607 shares of the company's stock valued at $2,318,000 after buying an additional 2,928 shares during the last quarter. Itau Unibanco Holding S.A. bought a new position in Celsius in the 2nd quarter worth approximately $45,000. Finally, Garden State Investment Advisory Services LLC acquired a new position in shares of Celsius during the second quarter worth approximately $206,000. 60.95% of the stock is owned by institutional investors.
Shares of NASDAQ:CELH opened at $32.53 on Friday. The company's fifty day moving average is $38.77 and its 200-day moving average is $62.37. Celsius Holdings, Inc. has a 52 week low of $30.86 and a 52 week high of $99.62. The company has a market capitalization of $7.58 billion, a PE ratio of 35.58, a P/E/G ratio of 2.45 and a beta of 1.85.
Celsius (NASDAQ:CELH - Get Free Report) last posted its earnings results on Tuesday, August 6th. The company reported $0.28 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.23 by $0.05. The company had revenue of $402.00 million during the quarter, compared to analysts' expectations of $391.07 million. Celsius had a net margin of 19.58% and a return on equity of 94.75%. Celsius's quarterly revenue was up 23.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.17 earnings per share. On average, analysts forecast that Celsius Holdings, Inc. will post 0.82 EPS for the current year.
CELH has been the topic of several research analyst reports. Jefferies Financial Group lowered their price objective on shares of Celsius from $68.00 to $53.00 and set a "buy" rating on the stock in a research note on Thursday, September 5th. Stifel Nicolaus dropped their price objective on shares of Celsius from $61.00 to $51.00 and set a "buy" rating on the stock in a report on Thursday, September 5th. UBS Group reduced their target price on shares of Celsius from $70.00 to $64.00 and set a "buy" rating for the company in a research note on Wednesday, August 7th. Wedbush lowered their price target on Celsius from $85.00 to $83.00 and set an "outperform" rating on the stock in a research note on Wednesday, June 12th. Finally, Truist Financial reduced their price objective on Celsius from $45.00 to $30.00 and set a "hold" rating for the company in a research report on Friday, September 6th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $57.29.
View Our Latest Report on CELH
In other news, CEO John Fieldly sold 74,847 shares of the firm's stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $32.80, for a total value of $2,454,981.60. Following the completion of the sale, the chief executive officer now directly owns 1,812,490 shares in the company, valued at $59,449,672. The sale was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 2.20% of the company's stock.
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Celsius, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celsius wasn't on the list.
While Celsius currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.